PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy
Introduction: Xerostomia is a well-known complication after iodine-131 ( 131 I) therapy for thyroid carcinoma. It is currently insufficiently understood how the dose and biodistribution of 131 I relates to salivary gland toxicity, and whether this is consistent for all salivary glands within a singl...
| Published in: | Molecular Imaging |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-07-01
|
| Online Access: | https://doi.org/10.1177/1536012120934992 |